Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Speciallægeselskabet, Klinik for Gynækologi og Fertilitet ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   0.0% 0.0% 5.0% 4.5% 2.9% 2.4% 8.7% 8.7%   Credit score (0-100)   0 0 43 45 58 62 28 28   Credit rating   N/A N/A BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   0.0 0.0 919 981 883 1,060 0.0 0.0   EBITDA   0.0 0.0 572 584 422 559 0.0 0.0   EBIT   0.0 0.0 443 435 272 410 0.0 0.0   Pre-tax profit (PTP)   0.0 0.0 420.0 420.0 272.5 360.7 0.0 0.0   Net earnings   0.0 0.0 327.0 326.0 211.0 279.2 0.0 0.0   Pre-tax profit without non-rec. items   0.0 0.0 420 420 272 361 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 204 154 104 54.2 0.0 0.0   Shareholders equity total   0.0 0.0 367 694 905 1,084 44.1 44.1   Interest-bearing liabilities   0.0 0.0 876 359 0.0 2,190 567 567   Balance sheet total (assets)   0.0 0.0 1,463 1,274 1,211 3,467 611 611   Net Debt   0.0 0.0 646 186 -114 2,190 567 567     See the entire balance sheet 1000.0 Volume  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   0.0 0.0 919 981 883 1,060 0.0 0.0   Gross profit growth   0.0% 0.0% 0.0% 6.7% -10.0% 20.1% -100.0% 0.0%   Employees   0 0 0 0 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   0 0 1,463 1,274 1,211 3,467 611 611   Balance sheet change%   0.0% 0.0% 0.0% -12.9% -4.9% 186.2% -82.4% 0.0%   Added value   0.0 0.0 572.0 584.0 421.5 559.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 983 -298 -298 -298 -54 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   0.0 0.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.0% 0.0% 48.2% 44.3% 30.8% 38.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.0% 0.0% 30.3% 31.8% 22.4% 17.8% 0.0% 0.0%   ROI %   0.0% 0.0% 33.2% 34.8% 26.5% 19.6% 0.0% 0.0%   ROE %   0.0% 0.0% 89.1% 61.5% 26.4% 28.1% 0.0% 0.0%   1000.0 Solidity  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 25.1% 54.5% 74.7% 31.3% 7.2% 7.2%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 112.9% 31.8% -27.1% 391.5% 0.0% 0.0%   Gearing %   0.0% 0.0% 238.7% 51.7% 0.0% 202.1% 1,285.2% 1,285.2%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 5.3% 2.4% 3.5% 5.0% 0.0% 0.0%   1000.0 Liquidity  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 1.2 1.2 1.4 1.2 0.0 0.0   Current Ratio   0.0 0.0 1.2 1.2 1.4 1.2 0.0 0.0   Cash and cash equivalent   0.0 0.0 230.0 173.0 114.4 0.0 0.0 0.0   1000.0 Capital use efficiency  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 0.0 64.0 54.0 77.7 365.7 -283.5 -283.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 N/A 2019 N/A 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 421 559 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 422 559 0 0   EBIT / employee   0 0 0 0 272 410 0 0   Net earnings / employee   0 0 0 0 211 279 0 0